- Home
- RMCF vs BFRI Comparison
RMCF vs BFRI Comparison
Compare RMCF & BFRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RMCF
- BFRI
- Stock Information
- Founded
- RMCF 1981
- BFRI 1997
- Country
- RMCF United States
- BFRI United States
- Employees
- RMCF N/A
- BFRI N/A
- Industry
- RMCF Specialty Foods
- BFRI Biotechnology: Pharmaceutical Preparations
- Sector
- RMCF Consumer Staples
- BFRI Health Care
- Exchange
- RMCF Nasdaq
- BFRI Nasdaq
- Market Cap
- RMCF 11.4M
- BFRI 11.4M
- IPO Year
- RMCF N/A
- BFRI 2021
- Fundamental
- Price
- RMCF $1.71
- BFRI $1.01
- Analyst Decision
- RMCF
- BFRI Strong Buy
- Analyst Count
- RMCF 0
- BFRI 1
- Target Price
- RMCF N/A
- BFRI $2.75
- AVG Volume (30 Days)
- RMCF 887.6K
- BFRI 100.4K
- Earning Date
- RMCF 10-13-2025
- BFRI 11-12-2025
- Dividend Yield
- RMCF N/A
- BFRI N/A
- EPS Growth
- RMCF N/A
- BFRI N/A
- EPS
- RMCF N/A
- BFRI N/A
- Revenue
- RMCF $29,545,000.00
- BFRI $39,188,000.00
- Revenue This Year
- RMCF N/A
- BFRI $9.70
- Revenue Next Year
- RMCF N/A
- BFRI $12.58
- P/E Ratio
- RMCF N/A
- BFRI N/A
- Revenue Growth
- RMCF 5.81
- BFRI 11.20
- 52 Week Low
- RMCF $1.12
- BFRI $0.54
- 52 Week High
- RMCF $3.49
- BFRI $2.22
- Technical
- Relative Strength Index (RSI)
- RMCF 49.48
- BFRI 66.56
- Support Level
- RMCF $1.55
- BFRI $1.00
- Resistance Level
- RMCF $1.87
- BFRI $1.09
- Average True Range (ATR)
- RMCF 0.13
- BFRI 0.07
- MACD
- RMCF -0.01
- BFRI 0.01
- Stochastic Oscillator
- RMCF 13.58
- BFRI 91.50
About RMCF Rocky Mountain Chocolate Factory Inc.
Rocky Mountain Chocolate Factory Inc operates as a manufacturer of chocolate candies and confectionery products. The business activity of the firm functions through Franchising, Manufacturing, Retail Stores, U-Swirl Operations, and Other t. The products of the company include varieties of Clusters, Caramels, Creams, Toffees, Mints, and Truffles.
About BFRI Biofrontera Inc.
Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions.